Main Session
Sep
29
SS 30 - Optimizing Therapy, Toxicity, and Supportive Care in Head & Neck Cancers
255 - The HYPCON Trial 2: A Phase II Randomized Study Evaluating Hypofractionated vs. Conventional Adjuvant Concurrent Chemoradiation in Head and Neck Malignancies
Presenter(s)
Aarcha Ramadas, MBBS - AIIMS New Delhi, New Delhi, Delhi